Market Cap 35.87B
Revenue (ttm) 15.46B
Net Income (ttm) 1.03B
EPS (ttm) N/A
PE Ratio 17.28
Forward PE 17.10
Profit Margin 6.66%
Debt to Equity Ratio 0.66
Volume 23,431,574
Avg Vol 47,247,684
Day's Range N/A - N/A
Shares Out 1.92B
Stochastic %K 94%
Beta 0.59
Analysts Sell
Price Target $19.18

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment...

Industry: Household & Personal Products
Sector: Consumer Defensive
Phone: 908-874-1200
Address:
1 Kenvue Way, Summit, United States
DragonAlgo
DragonAlgo Feb. 24 at 6:41 AM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-02-27 | Strike: $19.00 | Type: CALL Option Plan (premium): Entry: $0.22 Stop: $0.16 TP1: $0.29 TP2: $0.37 TP3: $0.53 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
DragonAlgo
DragonAlgo Feb. 23 at 1:22 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-02-27 | Strike: $18.50 | Type: CALL Option Plan (premium): Entry: $0.38 Stop: $0.27 TP1: $0.49 TP2: $0.65 TP3: $0.91 System-defined risk profile. 🔗 https://dragonalgo.com
0 · Reply
Suite510
Suite510 Feb. 23 at 11:11 AM
$JNJ $KVUE ⚠️ Ongoing talc litigation across tens of thousands of cases could lead to sizeable aggregate legal costs, settlements, or jury awards over multiple years. ⚠️ Repeated adverse verdicts may affect Johnson & Johnson’s brand perception in consumer health products
1 · Reply
Suite510
Suite510 Feb. 23 at 1:26 AM
$JNJ $KVUE $LLYX.X JNJ has lost every Talc Trial since their Fake 3rd Bankruptcy was dissmissed in March 2025 $30B to $50B Liability at Stake Here comes the downgrades and business segment sales 🤣🐻
1 · Reply
DailyAnalysis
DailyAnalysis Feb. 21 at 6:35 PM
$KVUE shows 1W strength as a defensive play, but 1D RSI suggests a healthy pullback. With 4H and 30M CCI rolling over, I am watching for a STOCH reset before the next activist-led leg up. @DailyAnalysis
0 · Reply
DragonAlgo
DragonAlgo Feb. 21 at 1:14 AM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-03-20 | Strike: $20.00 | Type: CALL Option Plan (premium): Entry: $0.08 Stop: $0.06 TP1: $0.11 TP2: $0.14 TP3: $0.20 🔗 https://dragonalgo.com
0 · Reply
Suite510
Suite510 Feb. 20 at 11:53 PM
$JNJ $KVUE $SPX $SPY Has expected Junk n Junk selling shit to pay THE BELOW ESTIMATED TALC BILL thank you very much 🤣 Johnson & Johnson explores $20 billion sale of orthopedics unit, source says lol 🙈🤣
0 · Reply
Suite510
Suite510 Feb. 20 at 10:26 PM
$JNJ $KVUE $SPX $SPY lol it’s happening 🤣🙈🐻
0 · Reply
bigmoneygrip9
bigmoneygrip9 Feb. 20 at 8:33 PM
$KVUE $KVUE bid coming from $UL chatter
0 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Feb. 20 at 3:27 PM
$KVUE holy shit this might hit my calls afterall. Tarrifs. Fuck. 21 strike march 20. Hope it doesnt break.
0 · Reply
Latest News on KVUE
Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

Feb 17, 2026, 5:50 PM EST - 6 days ago

Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal


Kenvue Reports Fourth Quarter and Full Year 2025 Results

Feb 17, 2026, 4:45 PM EST - 7 days ago

Kenvue Reports Fourth Quarter and Full Year 2025 Results


Dividend Kings: No Ideal Buys In February's 57

Feb 10, 2026, 9:45 AM EST - 14 days ago

Dividend Kings: No Ideal Buys In February's 57

ABBV ABM ADP CWT FRT FTS HRL


Kenvue Declares Quarterly Cash Dividend

Jan 28, 2026, 6:45 AM EST - 27 days ago

Kenvue Declares Quarterly Cash Dividend


Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

Jan 27, 2026, 6:40 AM EST - 4 weeks ago

Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

KMB


Best Dividend Kings: January 2026

Jan 25, 2026, 10:11 PM EST - 4 weeks ago

Best Dividend Kings: January 2026

ABBV ABM ABT ADM ADP AWR BDX


Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 7 weeks ago

Best Dividend Aristocrats For January 2026

ABBV ABT ADM ADP AFL ALB AMCR


Best Dividend Kings: December 2025

Dec 28, 2025, 6:44 AM EST - 2 months ago

Best Dividend Kings: December 2025

ABBV ABM ABT ADM ADP AWR BDX


Dividend Kings: 3 Ideal Buys In 56 For December

Dec 11, 2025, 5:50 PM EST - 2 months ago

Dividend Kings: 3 Ideal Buys In 56 For December

MO UBSI


Kenvue: Worth Owning As Kimberly-Clark Deal Plays Out

Dec 5, 2025, 1:36 PM EST - 2 months ago

Kenvue: Worth Owning As Kimberly-Clark Deal Plays Out


Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 3 months ago

Best Dividend Aristocrats For December 2025

ABBV ABT ADM ADP AFL ALB AMCR


US appeals court to weigh reviving cases over Tylenol and autism

Nov 17, 2025, 6:07 AM EST - 3 months ago

US appeals court to weigh reviving cases over Tylenol and autism


Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Nov 6, 2025, 8:06 AM EST - 3 months ago

Texas seeks to block Kenvue dividend amid Tylenol lawsuit


Watch These Stocks Falling 10% Or More

Nov 4, 2025, 4:58 PM EST - 4 months ago

Watch These Stocks Falling 10% Or More

AJG ARE BAX BRO CAVA CMG DECK


Explainer: Is Tylenol safe to take during pregnancy?

Nov 3, 2025, 3:29 PM EST - 4 months ago

Explainer: Is Tylenol safe to take during pregnancy?

KMB


Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

Nov 3, 2025, 11:18 AM EST - 4 months ago

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

KMB


Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal

Nov 3, 2025, 9:30 AM EST - 4 months ago

Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal


DragonAlgo
DragonAlgo Feb. 24 at 6:41 AM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-02-27 | Strike: $19.00 | Type: CALL Option Plan (premium): Entry: $0.22 Stop: $0.16 TP1: $0.29 TP2: $0.37 TP3: $0.53 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
DragonAlgo
DragonAlgo Feb. 23 at 1:22 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-02-27 | Strike: $18.50 | Type: CALL Option Plan (premium): Entry: $0.38 Stop: $0.27 TP1: $0.49 TP2: $0.65 TP3: $0.91 System-defined risk profile. 🔗 https://dragonalgo.com
0 · Reply
Suite510
Suite510 Feb. 23 at 11:11 AM
$JNJ $KVUE ⚠️ Ongoing talc litigation across tens of thousands of cases could lead to sizeable aggregate legal costs, settlements, or jury awards over multiple years. ⚠️ Repeated adverse verdicts may affect Johnson & Johnson’s brand perception in consumer health products
1 · Reply
Suite510
Suite510 Feb. 23 at 1:26 AM
$JNJ $KVUE $LLYX.X JNJ has lost every Talc Trial since their Fake 3rd Bankruptcy was dissmissed in March 2025 $30B to $50B Liability at Stake Here comes the downgrades and business segment sales 🤣🐻
1 · Reply
DailyAnalysis
DailyAnalysis Feb. 21 at 6:35 PM
$KVUE shows 1W strength as a defensive play, but 1D RSI suggests a healthy pullback. With 4H and 30M CCI rolling over, I am watching for a STOCH reset before the next activist-led leg up. @DailyAnalysis
0 · Reply
DragonAlgo
DragonAlgo Feb. 21 at 1:14 AM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-03-20 | Strike: $20.00 | Type: CALL Option Plan (premium): Entry: $0.08 Stop: $0.06 TP1: $0.11 TP2: $0.14 TP3: $0.20 🔗 https://dragonalgo.com
0 · Reply
Suite510
Suite510 Feb. 20 at 11:53 PM
$JNJ $KVUE $SPX $SPY Has expected Junk n Junk selling shit to pay THE BELOW ESTIMATED TALC BILL thank you very much 🤣 Johnson & Johnson explores $20 billion sale of orthopedics unit, source says lol 🙈🤣
0 · Reply
Suite510
Suite510 Feb. 20 at 10:26 PM
$JNJ $KVUE $SPX $SPY lol it’s happening 🤣🙈🐻
0 · Reply
bigmoneygrip9
bigmoneygrip9 Feb. 20 at 8:33 PM
$KVUE $KVUE bid coming from $UL chatter
0 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Feb. 20 at 3:27 PM
$KVUE holy shit this might hit my calls afterall. Tarrifs. Fuck. 21 strike march 20. Hope it doesnt break.
0 · Reply
GPALIMITBREAK
GPALIMITBREAK Feb. 20 at 3:19 PM
$KVUE 19 Call 2/20 at 0.06 🚨
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 20 at 2:00 PM
$KVUE shows a 1D Keltner squeeze following its Q4 earnings beat. 1W Vol Stop remains neutral while 4H BBs indicate low volatility. 30M momentum is flat as margins improve post-spinoff. @DailyAnalysis
0 · Reply
DragonAlgo
DragonAlgo Feb. 20 at 6:42 AM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-02-20 | Strike: $18.50 | Type: CALL Option Plan (premium): Entry: $0.25 Stop: $0.18 TP1: $0.33 TP2: $0.42 TP3: $0.60 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
LinFutures
LinFutures Feb. 19 at 8:26 PM
$KVUE defensive consumer health and if risk-off flows appear rot
0 · Reply
Cucumberlake
Cucumberlake Feb. 19 at 1:38 PM
$KVUE takeover candidate
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 19 at 1:25 PM
$KVUE is grinding with a solid 1W setup. 1D RSI is healthy but the 30M STOCH is getting frothy. Wait for the 4H CCI to cool before adding more size. @DailyAnalysis
0 · Reply
CapitalMonk
CapitalMonk Feb. 19 at 12:57 PM
$KVUE Price: $18.88 (+2.55%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.47% RSI: 83.0 | Momentum: Moderate Volume: -18.7% vs avg Volatility: 1.26% Support: $16.94 | Resistance: $18.97
0 · Reply
DragonAlgo
DragonAlgo Feb. 19 at 12:19 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-02-20 | Strike: $19.00 | Type: CALL Option Plan (premium): Entry: $0.14 Stop: $0.10 TP1: $0.18 TP2: $0.24 TP3: $0.34 Rules-based execution profile. 🔗 https://dragonalgo.com
0 · Reply
Growth_Gains
Growth_Gains Feb. 18 at 10:40 PM
I opened (7) new trades against the following tickers: $BULL, $TTD, $KVUE, $MP, & $BBAI, expiration Friday: Total premium rec’d — $467.18 💸 https://medium.com/@growthgains/my-investment-journal-how-i-make-3-000-per-week-ceaea12a0501
0 · Reply
Sami2021
Sami2021 Feb. 18 at 9:40 PM
$RIOT $KVUE $MTCH $CRM that is why RIOT is pumping today $MARA
0 · Reply
LubenDamianov
LubenDamianov Feb. 18 at 8:21 PM
$KVUE SOLD my Kenvue shares at 18.88 level for +32% gain plus 2 dividend payouts for the duration I held the position.
0 · Reply
erevnon
erevnon Feb. 18 at 7:38 PM
Citigroup maintains Kenvue $KVUE at Neutral and raises the price target from $18 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply